Full-Time

District Account Manager

Biologics

Smith+Nephew

Smith+Nephew

10,001+ employees

Global medical devices for orthopedics

Compensation Overview

$65k - $75k/yr

+ Sales Commission + Incentives

Bronx, NY, USA + 5 more

More locations: Long Island, New York, USA | Union City, NJ, USA | New York, NY, USA | Brooklyn, NY, USA | Queens, NY, USA

Remote

Remote role; up to 20% travel within the territory.

Category
Sales & Account Management (1)
Required Skills
Sales

Get referred to Smith+Nephew

See people who can refer or advise you

Requirements
  • Bachelor’s degree; primary focus business or sales
  • Ability to obtain necessary vendor credentialing required of the customer locations within assigned territories
Responsibilities
  • Support Account Manager(s) to address the business needs and goals within their territories and across the district. Collaborate virtually with key accounts and prospecting to find new business as needed.
  • Use your organizational skills to document and communicate daily updates to your district manager and supported reps according to agreed upon metrics.
  • Communicate and coordinate availability and use of products virtually across multiple sites of care.
  • Utilize virtual selling platforms and tools to conduct product education, pull through and sales calls.
  • Support and educate end users of our products; on the key features and benefits of your product mix.
  • Penetrate and maneuver virtually through target accounts
Desired Qualifications
  • Previous B2B telephone or virtual sales is a plus.
  • Willingness and ability to relocate within the territory or region in order to accommodate business need when an open territory does become available.
  • Travel 20%

Smith+Nephew is a global medical technology company that designs and makes medical devices for orthopaedics, sports medicine, and advanced wound care. Its products help surgeons treat joints and soft tissues and support patient recovery, including knee repair systems, single-use negative pressure wound therapy devices, and other extremity orthopaedic products. These devices are used in hospitals and clinics to perform procedures and support healing, often after surgery or injury. The company differentiates itself with a broad, worldwide product portfolio and collaborations with healthcare organizations to improve care and efficiency for patients and providers. Its goal is to improve patient outcomes, streamline medical procedures, and expand access to advanced medical solutions around the world.

Company Size

10,001+

Company Stage

IPO

Headquarters

Watford, United Kingdom

Founded

1856

Get referred to Smith+Nephew

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ASC Solutions can deepen relationships with physician groups and health systems.
  • CORI XT clinical cases support broader adoption in knee and shoulder arthroplasty.
  • Global operations across ~100 countries support commercial reach and product distribution.[6]

What critics are saying

  • Stryker, Zimmer Biomet, and Johnson & Johnson can slow robotics share gains.
  • ASC buildouts depend on capital budgets and vendor-standardization decisions.
  • Robotics adoption remains vulnerable to training, workflow, and reliability failures.

What makes Smith+Nephew unique

  • Smith+Nephew focuses on soft and hard tissue repair across orthopaedics, sports medicine, and wound care.[1][6]
  • ASC Solutions bundles facility design, construction, financing, and clinical enablement into one platform.
  • CORI XT is a handheld robotics platform built for both hospital and ASC procedures.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Holidays

Flexible Work Hours

Parental Leave

Fertility Treatment Support

Family Planning Benefits

Tuition Reimbursement

Wellness Program

Mental Health Support

Volunteer Time Off

Home Office Stipend

Phone/Internet Stipend

Discounted Stock Options

Health Savings Account/Flexible Spending Account

Employee Assistance Program

PTO/vacation?

Paid Sick Leave

Company News

Yahoo Finance
Mar 4th, 2026
Smith & Nephew reports $6.2B revenue with 5.3% growth and 53% jump in free cash flow

Smith & Nephew reported strong full-year 2025 results, with revenue of $6.2 billion representing 5.3% underlying growth and 6.1% reported growth. Fourth-quarter revenue reached $1.7 billion, growing 6.2% on an underlying basis. The medical device company achieved 160 basis points of margin expansion, with trading profit of $1.2 billion and adjusted earnings per share of $1.02, up 21%. Free cash flow increased 52.5% year-on-year to $840 million, enabling completion of a $500 million share buyback programme. Innovation drove over 60% of growth, with products launched in the past five years delivering double-digit growth across all business units. For 2026, the company expects 6% organic revenue growth and 8% trading profit growth to around $1.3 billion, though it faces headwinds from Chinese pricing reforms and US reimbursement changes.

Yahoo Finance
Feb 25th, 2026
Smith & Nephew signs exclusive US distribution deal with RMR Ortho for A'TOMIC Nitinol Fixation System

Smith+Nephew has signed an exclusive US distribution agreement with RMR Ortho to add the A'TOMIC Nitinol Fixation System to its Trauma, Foot & Ankle and Hand & Wrist portfolio. The partnership enables Smith+Nephew to expand its participation in high-frequency fracture and arthrodesis procedures whilst utilising its existing Extremities and Trauma sales channel. The dynamic compression fixation solution complements the company's current technologies. Scott Gunn, Vice President of US Marketing at Smith+Nephew, said the collaboration reflects the company's disciplined approach to portfolio expansion and continued focus on driving sustainable growth.

Investegate Ltd
Jan 12th, 2026
Smith+Nephew acquires Integrity Orthopaedics for $225M plus $225M in performance payments

Smith+Nephew has acquired Integrity Orthopaedics for an initial $225 million cash payment, plus up to $225 million in performance-based payments over five years. The deal strengthens Smith+Nephew's sports medicine portfolio with the Tendon Seam rotator cuff repair technology. Founded in 2020, Integrity Orthopaedics developed the innovative system to address high failure rates in traditional rotator cuff repairs. The technology uses patented micro-anchors and continuous suture designed to deliver stronger repairs and lower re-tear rates. Early clinical results show reduced pain and shorter recovery times. The rotator cuff repair market performs approximately 500,000 procedures annually in the US, valued at $875 million. The acquisition, expected to close by end of January 2026, will be financed from existing cash facilities and is expected to be accretive to trading profit margin by 2028.

Startupticker.ch
Jun 2nd, 2025
Smith & Nephew acquires Atracsys to expand its digital surgery ecosystem

Download the Swiss reference publication on investments, investors and exits in our assets section.

The Manila Times
Mar 11th, 2025
Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025

Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for robotics, knees, hips, and shoulders at AAOS 2025.